Related Experiment Video
Updated: Jul 9, 2026
10:50
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration
Katrin Färber1, Sören Markworth, Ulrike Pannasch
1Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Glia
|December 22, 2007
Summary
Microglia migration requires both purinergic and adenosine receptor co-stimulation. The enzyme CD39 is crucial for this process by balancing adenosine levels, impacting brain injury responses.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the brain's immune cells, are activated by injury.
- Microglial migration is essential for clearing debris and initiating repair.
- ATP and adenosine are key signaling molecules in the brain.
Purpose of the Study:
- To investigate the role of CD39 in microglial migration.
- To determine the necessity of adenosine co-stimulation for ATP-induced microglial migration.
- To elucidate the ATP/adenosine balance controlled by CD39 in microglial responses.
Main Methods:
- Utilized wild-type and CD39-deficient (cd39(-/-)) microglia.
- Assessed microglial migration in response to ATP and adenosine.
- Examined microglial accumulation in models of brain injury (ischemia, entorhinal cortex lesion, facial nerve lesion).
Main Results:
- ATP-triggered microglial migration was impaired in cd39(-/-) microglia.
- Adenosine co-stimulation or addition of soluble ectonucleotidase restored ATP-induced migration in cd39(-/-) microglia.
- Microglial accumulation at pathological sites was significantly reduced in cd39(-/-) animals.
Conclusions:
- Co-stimulation of purinergic and adenosine receptors is essential for microglial migration.
- CD39 plays a critical role in regulating the ATP/adenosine balance, thereby controlling microglial migration.
- Targeting CD39 could modulate microglial responses in neurological disorders.
